Press / media

How can cell-based immunotherapies for cancer and autoimmune diseases become more widely available in the long term? The SYNTHIA project is addressing this challenge: The Fraunhofer Institute for Cell Therapy and Immunology IZI and the Max Planck Institute for Medical Research (MPIMR) are collaborating on new research approaches to advance the development of cell-based immunotherapies. The three-year project is funded through the Fraunhofer–Max Planck Cooperation Program.

From September 8 to 11, the floating science center MS Wissenschaft was moored in Würzburg. Its exhibits included a presentation on CAR T-cell therapy developed by the University of Würzburg, Würzburg University Hospital, and Fraunhofer IZI.

Professor Zoltán Ivics, head of the Clinical Gene Transfer Unit at the Fraunhofer Institute for Cell Therapy and Immunology IZI, has been elected as a new member of the European Molecular Biology Organization (EMBO). This membership recognizes his outstanding contributions to molecular and cell biology.

The theme of Science Year 2026 is “Medicine of the Future.” At MS Wissenschaft, the floating science center touring Germany and Austria from May 7 to September 30, this year’s focus is on how researchers are already developing the medicine of tomorrow.